PM
PharmaCyte Biotech, Inc.
PMCB · NASDAQ
$0.45 +8.08% (+$0.03)
1M -13.75%
Market Cap $4.41M
P/E Ratio -
Div. Yield -
ROE 60.42%
Piotroski F-Score Weak
2/9Valuation
90 /100
Cheap P/B 1.91x
EV/FFO N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 2,751.79%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 45.90%
ROIC 83.13%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 40.30x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
37 /100
Moderate Profitable years 0
Beta 0.66x
EPS volatility 250.18%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PMCB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joshua N. Silverman
Employees
2
Headquarters
Las Vegas
Prihajajoči dogodki
16 DEC.
Earnings
Upcoming earnings report